Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Equity Ratio (2016 - 2025)

Amphastar Pharmaceuticals (AMPH) has 13 years of Equity Ratio data on record, last reported at 0.47 in Q3 2025.

  • For Q3 2025, Equity Ratio fell 1.01% year-over-year to 0.47; the TTM value through Sep 2025 reached 0.47, down 1.01%, while the annual FY2024 figure was 0.46, 9.84% up from the prior year.
  • Equity Ratio reached 0.47 in Q3 2025 per AMPH's latest filing, down from 0.47 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.71 in Q4 2022 and bottomed at 0.39 in Q3 2023.
  • Average Equity Ratio over 5 years is 0.56, with a median of 0.48 recorded in 2024.
  • Peak YoY movement for Equity Ratio: tumbled 44.57% in 2023, then grew 22.23% in 2024.
  • A 5-year view of Equity Ratio shows it stood at 0.66 in 2021, then rose by 7.39% to 0.71 in 2022, then crashed by 40.68% to 0.42 in 2023, then grew by 9.84% to 0.46 in 2024, then increased by 0.42% to 0.47 in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Ratio were 0.47 in Q3 2025, 0.47 in Q2 2025, and 0.46 in Q1 2025.